The 298 unique DEGs from asthma cases in response to IL-13+IL-17A treatment were enriched for “cadherin binding” (adj Pcases = 9.0 × 10−7, Pcontrols = 0.067), while the 2717 unique DEGs from controls were enriched for “enzyme binding” (adj Pcontrols = 8.4 × 10−4, Pcases = 0.11). Here, IL17A is linked to asthma.